ASKA Pharmaceutical Holdings Co (TSE:4886) Total Inventories : 円19,713 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Total Inventories?

ASKA Pharmaceutical Holdings Co's total inventories for the quarter that ended in Dec. 2023 was 円19,713 Mil. ASKA Pharmaceutical Holdings Co's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was 円19,150 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. ASKA Pharmaceutical Holdings Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was 円334.96.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. ASKA Pharmaceutical Holdings Co's Days Inventory for the three months ended in Dec. 2023 was 200.14.

Inventory Turnover measures how fast the company turns over its inventory within a year. ASKA Pharmaceutical Holdings Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.46.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ASKA Pharmaceutical Holdings Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.11.

ASKA Pharmaceutical Holdings Co Total Inventories Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Total Inventories Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Total Inventories

15,060.00

17,687.00

20,402.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Inventories	Get a 7-Day Free Trial							17,687.00	17,501.00	18,586.00	19,713.00	20,402.00

ASKA Pharmaceutical Holdings Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

ASKA Pharmaceutical Holdings Co (TSE:4886) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

ASKA Pharmaceutical Holdings Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(20354	+	0.75 * 18307	+	0.5 * 19713	-	34467
-	0	-	0)	/	28.2832
=	334.96

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ASKA Pharmaceutical Holdings Co's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	19149.5	/	8731	*	365 / 4
	=	200.14

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

ASKA Pharmaceutical Holdings Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	8731	/	19149.5
	=	0.46

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ASKA Pharmaceutical Holdings Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	19149.5	/	17176
	=	1.11

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

ASKA Pharmaceutical Holdings Co Total Inventories Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines